NCT04978350Completed
Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
Source: ClinicalTrials.gov · Last updated 3 Jul 2025
Brief summary (registry, in English)
The investigators will evaluate the feasibility of an intervention to improve Lynch syndrome cascade screening uptake. The investigators will conduct a pilot study among 15 patients diagnosed with Lynch Syndrome and 5 genetic counselors to assess the feasibility and intermediate outcomes of an educational workbook containing exercises and resources to improve family communication among individuals with Lynch Syndrome and first-degree relatives of individuals with Lynch Syndrome.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 22 Jun 2021
- Start date
- 1 Aug 2021
- Primary completion date
- 2 May 2024
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- NCT number
- NCT04978350
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 1 Aug 2021 to the primary completion date, 2 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients must have been diagnosed with Lynch Syndrome within the last 365 days.
- Patients and genetic counselors must be age 18 or older.
- Patients must be receiving care from genetic counselors at Ohio State University Comprehensive Cancer Center or at UNC Health System.
- Genetic counselors must provide Lynch Syndrome counseling for patient participants at Ohio State University Comprehensive Cancer Center or at UNC Health System.
- Patients and genetic counselors must be able to speak and read in English.
- Patients and genetic counselors must review informed consent documents and provide verbal consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of North Carolina at Chapel Hill Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.